The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Toward understanding Machado–Joseph disease
Open accessAbstract
Machado-Joseph disease (MJD), also known as Spinocerebellar ataxia type 3 (SCA3), is the most common inherited spinocerebellar ataxia and one of many polyglutamine neurodegenerative diseases. In MJD, a CAG repeat expansion encodes an abnormally long polyglutamine (polyQ) tract in the disease protein, ATXN3. Here we review MJD, focusing primarily on the function and dysfunction of ATXN3 and on advances toward potential therapies. ATXN3 is a deubiquitinating enzyme (DUB) whose highly specialized properties suggest that it participates in ubiquitin-dependent proteostasis. By virtue of its interactions with VCP, various ubiquitin ligases and other ubiquitin-linked proteins, ATXN3 may help regulate the stability or activity of many proteins in diverse cellular pathways implicated in proteotoxic stress response, aging, and cell differentiation. Expansion of the polyQ tract in ATXN3 is thought to promote an altered conformation in the protein, leading to changes in interactions with native partners and to the formation of insoluble aggregates. The development of a wide range of cellular and animal models of MJD has been crucial to the emerging understanding of ATXN3 dysfunction upon polyQ expansion. Despite many advances, however, the principal molecular mechanisms by which mutant ATXN3 elicits neurotoxicity remain elusive. In a chronic degenerative disease like MJD, it is conceivable that mutant ATXN3 triggers multiple, interconnected pathogenic cascades that precipitate cellular dysfunction and eventual cell death. A better understanding of these complex molecular mechanisms will be important as scientists and clinicians begin to focus on developing effective therapies for this incurable, fatal disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,237
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. R. L., Wilson, E. M., Lubahn, D. B., Harding, A. E., & Fischbeck, K. H. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,784
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-221 · Cited by 1,753
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis
Schöls, L., Bauer, P., Schmidt, T., Schulte, T., & Riess, O. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00737-9 · Cited by 1,058
Mapping of DNA Instability at the Fragile X to a Trinucleotide Repeat Sequence P(CCG) n
Kremer, E. J., Pritchard, M., Lynch, M., Yu, S., Holman, K., Baker, E., Warren, S. T., Schlessinger, D., Sutherland, G. R., & Richards, R. I. (1991) · Science · doi:10.1126/science.1675488 · Cited by 908
Warrick, J. M., Chan, H. Y. E., Gray-Board, G. L., Chai, Y., Paulson, H. L., & Bonini, N. M. (1999) · Nature Genetics · doi:10.1038/70532 · Cited by 830
Self-citationIntranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3
Paulson, H. L., Perez, M. K., Trottier, Y., Trojanowski, J. Q., Subramony, S. H., Das, S. S., Vig, P., Mandel, J.-L., Fischbeck, K. H., & Pittman, R. N. (1997) · Neuron · doi:10.1016/s0896-6273(00)80943-5 · Cited by 830
Self-citationLim, J., Hao, T., Shaw, C., Patel, A. J., Szabó, G., Rual, J.-F., Fisk, C. J., Li, N., Smolyar, A., Hill, D. E., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.032 · Cited by 789
Expanded Polyglutamine Protein Forms Nuclear Inclusions and Causes Neural Degeneration in Drosophila
Warrick, J. M., Paulson, H. L., Gray-Board, G. L., Bui, Q. T., Fischbeck, K. H., Pittman, R. N., & Bonini, N. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81200-3 · Cited by 668
Self-citationRapamycin alleviates toxicity of different aggregate-prone proteins
Berger, Z., Ravikumar, B., Menzies, F. M., Oroz, L. G., Underwood, B. R., Pangalos, M. N., Schmitt, I., Wullner, U., Evert, B. O., O'Kane, C. J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi458 · Cited by 657
Wellington, C. L., Ellerby, L. M., Hackam, A. S., Margolis, R. L., Trifiro, M. A., Singaraja, R., McCutcheon, K., Salvesen, G. S., Propp, S. S., Bromm, M., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9158 · Cited by 562
Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo
Ikeda, H., Yamaguchi, M., Sugai, S., Aze, Y., Narumiya, S., & Kakizuka, A. (1996) · Nature Genetics · doi:10.1038/ng0696-196 · Cited by 545
Amyloid fibers are water-filled nanotubes
Perutz, M. F., Finch, J. T., Berriman, J., & Lesk, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042681399 · Cited by 506
Durr, A., Stevanin, G., Cancel, G., Duyckaerts, C., Abbas, N., Didierjean, O., Chneiweiss, H., Benomar, A., Lyon‐Caen, O., Julien, J., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390411 · Cited by 437
Analysis of the Role of Heat Shock Protein (Hsp) Molecular Chaperones in Polyglutamine Disease
Chai, Y., Koppenhafer, S. L., Bonini, N. M., & Paulson, H. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10338.1999 · Cited by 421
Self-citationChai, Y., Koppenhafer, S. L., Shoesmith, S. J., Perez, M. K., & Paulson, H. L. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.673 · Cited by 404
Self-citationBurnett, B. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg344 · Cited by 373
The gene for Machado–Joseph disease maps to human chromosome 14q
Takiyama, Y., Nishizawa, M., Tanaka, H., Kawashima, S., Sakamoto, H., Karube, Y., Shimazaki, H., Soutome, M., Endo, K., Ohta, S., et al. (1993) · Nature Genetics · doi:10.1038/ng0793-300 · Cited by 344
Polyglutamine neurodegeneration: protein misfolding revisited
Williams, A. J., & Paulson, H. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.004 · Cited by 341
Self-citationA toxic monomeric conformer of the polyglutamine protein
Nagai, Y., Inui, T., Popiel, H. A., Fujikake, N., Hasegawa, K., Urade, Y., Goto, Y., Naiki, H., & Toda, T. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1215 · Cited by 333
Jana, N. R., Dikshit, P., Goswami, A., Kotliarova, S., Murata, S., Tanaka, K., & Nukina, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412042200 · Cited by 323
RNA toxicity is a component of ataxin-3 degeneration in Drosophila
Li, L.-B., Yu, Z., Teng, X., & Bonini, N. M. (2008) · Nature · doi:10.1038/nature06909 · Cited by 316 · cited 1×
“Although a hyperexpanded CAG repeat RNA transcript is toxic and causes degeneration in a Drosophila model of MJD (Li et al., 2008), most evidence suggests that the key toxic species is instead the mutant ATXN3 protein with its polyQ expansion.”
BackgroundRecruitment and the Role of Nuclear Localization in Polyglutamine-mediated Aggregation
Perez, M. K., Paulson, H. L., Pendse, S. J., Saionz, S. J., Bonini, N. M., & Pittman, R. N. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.6.1457 · Cited by 314
Self-citationCorrelation between CAG repeat length and clinical features in Machado-Joseph disease.
Maciel, P., Gaspar, C., DeStefano, A. L., Silveira, I., Coutinho, P., Radvany, J., Dawson, D. M., Sudarsky, L. R., Guimarães, J., & Loureiro, J. L. (1995) · PubMed Central · Cited by 312
Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1
Lim, J., Crespo-Barreto, J., Jafar-Nejad, P., Bowman, A. B., Richman, R., Hill, D. E., Orr, H. T., & Zoghbi, H. Y. (2008) · Nature · doi:10.1038/nature06731 · Cited by 311 · cited 6×
“Lin-10 Lin-10 Lim et al. (2006)”
BackgroundInfluentialDeranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2
Liu, J., Tang, T.-S., Tu, H., Nelson, O., Herndon, E., Huynh, D. P., Pulst, S. M., & Bezprozvanny, I. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0660-09.2009 · Cited by 299
COUTINHO, P., & ANDRADE, C. (1978) · Neurology · doi:10.1212/wnl.28.7.703 · Cited by 289
Gispert, S., Twells, R., Orozco, G., Brice, A., Weber, J., Heredero, L., Scheufler, K., Riley, B., Allotey, R., Nothers, C., et al. (1993) · Nature Genetics · doi:10.1038/ng0793-295 · Cited by 285
Tsai, Y. C., Fishman, P. S., Thakor, N. V., & Oyler, G. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212235200 · Cited by 283
Machado‐Joseph disease gene product is a cytoplasmic protein widely expressed in brain
Paulson, H. L., Das, S. S., Crino, P. B., Perez, M. K., Patel, S. C., Gotsdiner, D., Fischbeck, K. H., & Pittman, R. N. (1997) · Annals of Neurology · doi:10.1002/ana.410410408 · Cited by 271
Self-citationWarrick, J. M., Morabito, L. M., Bilen, J., Gordesky-Gold, B., Faust, L. Z., Paulson, H. L., & Bonini, N. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.030 · Cited by 267
Self-citationWinborn, B. J., Travis, S. M., Todi, S. V., Scaglione, K. M., Xu, P., Williams, A. J., Cohen, R. E., Peng, J., & Paulson, H. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803692200 · Cited by 263
Self-citationMenzies, F. M., Huebener, J., Renna, M., Bonin, M., Riess, O., & Rubinsztein, D. C. (2010) · Brain · doi:10.1093/brain/awp292 · Cited by 262
When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases
Ross, C. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90138-8 · Cited by 260
Hu, J., Matsui, M., Gagnon, K. T., Schwartz, J. C., Gabillet, S., Arar, K., Wu, J., Bezprozvanny, I., & Corey, D. R. (2009) · Nature Biotechnology · doi:10.1038/nbt.1539 · Cited by 243
Doss-Pepe, E. W., Stenroos, E. S., Johnson, W. G., & Madura, K. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6469-6483.2003 · Cited by 237
Zoghbi, H. Y., & Orr, H. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800041200 · Cited by 227
Machado disease: A hereditary ataxia in Portuguese emigrants to Massachusetts
Nakano, K. K., Dawson, D. M., & Spence, A. (1972) · Neurology · doi:10.1212/wnl.22.1.49 · Cited by 226
Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates
Donaldson, K. M., Li, W., Ching, K. A., Batalov, S., Tsai, C.-C., & Joazeiro, C. A. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530212100 · Cited by 225
SCA3: Neurological features, pathogenesis and animal models
Riess, O., Rüb, U., Pastore, A., Bauer, P., & Schöls, L. (2008) · The Cerebellum · doi:10.1007/s12311-008-0013-4 · Cited by 224
Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3
Chen, X., Tang, T.-S., Tu, H., Nelson, O., Pook, M., Hammer, R., Nukina, N., & Bezprozvanny, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3909-08.2008 · Cited by 218
Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3
Bürk, K., Globas, C., Bösch, S., Klockgether, T., Zühlke, C., Daum, I., & Dichgans, J. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0976-5 · Cited by 217
Shakkottai, V. G., do Carmo Costa, M., Dell'Orco, J. M., Sankaranarayanan, A., Wulff, H., & Paulson, H. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2789-11.2011 · Cited by 214
Self-citationCemal, C. K. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1075 · Cited by 214
Ataxin-3 Is a Histone-binding Protein with Two Independent Transcriptional Corepressor Activities
Li, F., Macfarlan, T., Pittman, R. N., & Chakravarti, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205259200 · Cited by 213
Schmidt, T., Landwehrmeyer, G. B., Schmitt, I., Trottier, Y., Auburger, G., Laccone, F., Klockgether, T., Völpel, M., Epplen, J. T., Schöls, L., et al. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00193.x · Cited by 210
Molecular features of the CAG repeats and clinical manifestation of Machado--Joseph disease
Maruyama, H., Nakamura, S., Matsuyama, Z., Sakai, T., Doyu, M., Sobue, G., Seto, M., Tsujihata, M., Oh-i, T., Nishio, T., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.5.807 · Cited by 209
Nascimento-Ferreira, I., Santos-Ferreira, T., Sousa-Ferreira, L., Auregan, G., Onofre, I., Alves, S., Dufour, N., Colomer Gould, V. F., Koeppen, A., Déglon, N., et al. (2011) · Brain · doi:10.1093/brain/awr047 · Cited by 204
Epidemiology and clinical aspects of Machado-Joseph disease.
Sequeiros, J., & Coutinho, P. (1993) · PubMed · Cited by 203
Chai, Y., Shao, J., Miller, V. M., Williams, A., & Paulson, H. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152101299 · Cited by 202
Self-citationAlves, S., Nascimento-Ferreira, I., Aurégan, G., Hässig, R., Dufour, N., Brouillet, E., de Lima, M. C. P., Hantraye, P., de Almeida, L. P., & Déglon, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003341 · Cited by 200
Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates
Zhong, X., & Pittman, R. N. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl164 · Cited by 200
Fujikake, N., Nagai, Y., Popiel, H. A., Okamoto, Y., Yamaguchi, M., & Toda, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710521200 · Cited by 199
ROSENBERG, R. N., NYHAN, W. L., BAY, C., & SHORE, P. (1976) · Neurology · doi:10.1212/wnl.26.8.703 · Cited by 198
The ubiquitination code: a signalling problem
Woelk, T., Sigismund, S., Penengo, L., & Polo, S. (2007) · Cell Division · doi:10.1186/1747-1028-2-11 · Cited by 197
Genome-Wide Screen for Modifiers of Ataxin-3 Neurodegeneration in Drosophila
Bilen, J., & Bonini, N. M. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030177 · Cited by 196
Bichelmeier, U., Schmidt, T., Hübener, J., Boy, J., Rüttiger, L., Häbig, K., Poths, S., Bonin, M., Knipper, M., Schmidt, W. J., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4540-06.2007 · Cited by 195
Goti, D., Katzen, S. M., Mez, J., Kurtis, N., Kiluk, J., Ben-Haïem, L., Jenkins, N. A., Copeland, N. G., Kakizuka, A., Sharp, A. H., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2734-04.2004 · Cited by 194
Nicastro, G., Menon, R. P., Masino, L., Knowles, P. P., McDonald, N. Q., & Pastore, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501732102 · Cited by 188
Ube2w and Ataxin-3 Coordinately Regulate the Ubiquitin Ligase CHIP
Scaglione, K. M., Zavodszky, E., Todi, S. V., Patury, S., Xu, P., Rodríguez-Lebrón, E., Fischer, S., Konen, J. R., Djarmati, A., Peng, J., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.036 · Cited by 185
Self-citationNew insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado–Joseph disease)
Rüb, U., Brunt, E. R., & Deller, T. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282f7673d · Cited by 184
Machado-Joseph Disease: from first descriptions to new perspectives
Bettencourt, C., & Lima, M. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-35 · Cited by 182
Polyglutamine diseases: The special case of ataxin-3 and Machado–Joseph disease
Matos, C. A., Macedo‐Ribeiro, S., & Carvalho, A. L. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.06.007 · Cited by 180
Chou, A.-H., Yeh, T.-H., Ouyang, P., Chen, Y.-L., Chen, S.-Y., & Wang, H.-L. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.03.011 · Cited by 180
Klockgether, T. (1998) · Brain · doi:10.1093/brain/121.9.1687 · Cited by 180
Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3
Wang, Q., Li, L., & Ye, Y. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200605100 · Cited by 179
The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies
Bauer, P. O., & Nukina, N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06302.x · Cited by 178
Berke, S. J. S., & Paulson, H. L. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00053-4 · Cited by 178
Self-citationNigro-spino-dentatal degeneration with nuclear ophthalmoplegia
Woods, B. T., & Schaumburg, H. H. (1972) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(72)90137-2 · Cited by 177
The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation
Burnett, B. G., & Pittman, R. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407252102 · Cited by 176
New Model for Crystalline Polyglutamine Assemblies and Their Connection with Amyloid Fibrils
Sikorski, P., & Atkins, E. (2005) · Biomacromolecules · doi:10.1021/bm0494388 · Cited by 172
Durcan, T. M., Kontogiannea, M., Thorarinsdottir, T., Fallon, L., Williams, A. J., Djarmati, A., Fantaneanu, T. A., Paulson, H. L., & Fon, E. A. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq452 · Cited by 171
Self-citationUbiquitination directly enhances activity of the deubiquitinating enzyme ataxin‐3
Todi, S. V., Winborn, B. J., Scaglione, K. M., Blount, J. R., Travis, S. M., & Paulson, H. L. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.289 · Cited by 171
Self-citationTherapeutics development for triplet repeat expansion diseases
Prospero, N. A. D., & Fischbeck, K. H. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1690 · Cited by 170
Chai, Y., Berke, S. S., Cohen, R. E., & Paulson, H. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310939200 · Cited by 169
Self-citationEvert, B. O., Vogt, I. R., Kindermann, C., Ozimek, L., de Vos, R. A. I., Brunt, E. R. P., Schmitt, I., Klockgether, T., & Wüllner, U. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05389.2001 · Cited by 167
Machado‐Joseph disease: An autosomal dominant motor system degeneration
Rosenberg, R. N. (1992) · Movement Disorders · doi:10.1002/mds.870070302 · Cited by 166
Molecular clearance of ataxin‐3 is regulated by a mammalian E4
Matsumoto, M., Yada, M., Hatakeyama, S., Ishimoto, H., Tanimura, T., Tsuji, S., Kakizuka, A., Kitagawa, M., & Nakayama, K. I. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600081 · Cited by 166
The Two-stage Pathway of Ataxin-3 Fibrillogenesis Involves a Polyglutamine-independent Step
Ellisdon, A. M., Thomas, B., & Bottomley, S. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601470200 · Cited by 164
Clinical criteria for diagnosis of Machado‐Joseph disease: Report of a non‐Azorean Portuguese family
Lima, L., & Coutinho, P. (1980) · Neurology · doi:10.1212/wnl.30.3.319 · Cited by 164
Evert, B. O., Araujo, J., Vieira-Saecker, A. M., de Vos, R. A. I., Harendza, S., Klockgether, T., & Wüllner, U. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2053-06.2006 · Cited by 162
Polyglutamine Diseases and Transport Problems: Deadly Traffic Jams on Neuronal Highways
Gunawardena, S., & Goldstein, L. S. B. (2005) · Archives of Neurology · doi:10.1001/archneur.62.1.46 · Cited by 162
Deubiquitinating function of ataxin-3: Insights from the solution structure of the Josephin domain
Mao, Y., Senic-Matuglia, F., Di Fiore, P. P., Polo, S., Hodsdon, M. E., & De Camilli, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506344102 · Cited by 162
Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination
Schmitt, I., Linden, M., Khazneh, H., Evert, B. O., Breuer, P., Klockgether, T., & Wuellner, U. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.062 · Cited by 161
Neurologic Findings in Machado-Joseph Disease: Relation With Disease Duration, Subtypes, and (CAG)n
Jardim, L. B., Pereira, M. L., Silveira, I., Ferro, A., Sequeiros, J., & Giugliani, R. (2001) · Archives of Neurology · doi:10.1001/archneur.58.6.899 · Cited by 160
Wang, G.-H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.12.1795 · Cited by 159
Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics
Scheel, H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg297 · Cited by 159
An arginine/lysine‐rich motif is crucial for VCP/p97‐mediated modulation of ataxin‐3 fibrillogenesis
Boeddrich, A., Gaumer, S., Haacke, A., Tzvetkov, N., Albrecht, M., Evert, B. O., Müller, E. C., Lurz, R., Breuer, P., Schugardt, N., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601043 · Cited by 157
Balancing act: deubiquitinating enzymes in the nervous system
Todi, S. V., & Paulson, H. L. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.004 · Cited by 154
Self-citationCAG repeat disorder models and human neuropathology: similarities and differences
Yamada, M., Sato, T., Tsuji, S., & Takahashi, H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0287-5 · Cited by 150
Kobayashi, T., Tanaka, K., Inoue, K., & Kakizuka, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207783200 · Cited by 147
Takiyama, Y., Igasrashi, S., Rogaeva, E. A., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.7.1137 · Cited by 140
Heterogeneous Intracellular Localization and Expression of Ataxin-3
Trottier, Y., Cancel‐Tassin, G., Gourfinkel‐An, I., Lutz, Y., Weber, C., Brice, A., Hirsch, É. C., & Mandel, J. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0208 · Cited by 139
Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3
Boy, J., Schmidt, T., Wolburg, H., Mack, A. F., Nuber, S., Böttcher, M., Schmitt, I., Holzmann, C., Zimmermann, F., Servadio, A., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp381 · Cited by 138
Alves, S., Nascimento-Ferreira, I., Dufour, N., Hässig, R., Aurégan, G., Nóbrega, C., Brouillet, E., Hantraye, P., de Lima, M. C. P., Déglon, N., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq111 · Cited by 134
Characteristic Magnetic Resonance Imaging Findings in Machado-Joseph Disease
Murata, Y., Yamaguchi, S., Kawakami, H., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.1.33 · Cited by 133
Teixeira‐Castro, A., Ailion, M., Jalles, A., Brignull, H. R., Vilaça, J. L., Dias, N. S., Rodrigues, P., Oliveira, J. F., Neves‐Carvalho, A., Morimoto, R. I., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr203 · Cited by 131
Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation
Ying, Z., Wang, H., Fan, H., Zhu, X., Zhou, J., Fei, E., & Wang, G. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp380 · Cited by 128
Haacke, A., Broadley, S. A., Boteva, R. N., Tzvetkov, N., Hartl, F. U., & Breuer, P. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi472 · Cited by 128
Calpain Inhibition Is Sufficient to Suppress Aggregation of Polyglutamine-expanded Ataxin-3
Haacke, A., Hartl, F. U., & Breuer, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611914200 · Cited by 126
Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders
Mori, F., Nishie, M., Piao, Y., Kito, K., Kamitani, T., Takahashi, H., & Wakabayashi, K. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00603.x · Cited by 122
Williams, A. J., Knutson, T. M., Gould, V. F. C., & Paulson, H. L. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.016 · Cited by 121
Self-citationAtaxin-3 is transported into the nucleus and associates with the nuclear matrix
Tait, D. S., Riccio, M., Sittler, A., Scherzinger, E., Santi, S., Ognibene, A., Maraldi, N. M., Lehrach, H., & Wanker, E. E. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.6.991 · Cited by 121
The Role of Protein Composition in Specifying Nuclear Inclusion Formation in Polyglutamine Disease
Chai, Y., Wu, L., Griffin, J. D., & Paulson, H. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106575200 · Cited by 116
Self-citationCK2-dependent phosphorylation determines cellular localization and stability of ataxin-3
Müeller, T., Breuer, P., Schmitt, I., Walter, J., Evert, B. O., & Wüllner, U. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp274 · Cited by 115
Lentivector‐mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia
Torashima, T., Koyama, C., Iizuka, A., Mitsumura, K., Takayama, K., Yanagi, S., Oue, M., Yamaguchi, H., & Hirai, H. (2008) · EMBO Reports · doi:10.1038/embor.2008.31 · Cited by 114
Proteotoxic stress increases nuclear localization of ataxin-3
Reina, C. P., Zhong, X., & Pittman, R. N. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp482 · Cited by 114
Paulson, H. L. (2007) · Seminars in Neurology · doi:10.1055/s-2007-971172 · Cited by 112
Self-citationEvert, B. O., Vogt, I. R., Vieira-Saecker, A. M. M., Ozimek, L., de Vos, R. A. I., Brunt, E. R. P., Klockgether, T., & Wüllner, U. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.10.1006 · Cited by 112
Caspase‐mediated proteolysis of the polyglutamine disease protein ataxin‐3
Berke, S. J. S., Schmied, F. A. F., Brunt, E. R. P., Ellerby, L., & Paulson, H. L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02369.x · Cited by 108
Self-citationYu, Y., Kuo, C., Cheng, W., Liu, C., & Hsieh, M. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22011 · Cited by 107
Defining the Role of Ubiquitin-interacting Motifs in the Polyglutamine Disease Protein, Ataxin-3
Berke, S. J. S., Chai, Y., Marrs, G. L., Wen, H., & Paulson, H. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506084200 · Cited by 105
Self-citationAxonal inclusions in spinocerebellar ataxia type 3
Seidel, K., den Dunnen, W. F. A., Schultz, C., Paulson, H. L., Frank, S., de Vos, R. A., Brunt, E. R. P., Deller, T., Kampinga, H. H., & Rüb, U. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0717-7 · Cited by 104
Self-citationRodrigues, A. J., Coppola, G., Santos, C. S., Costa, M. D. C., Ailion, M., Sequeiros, J., Geschwind, D. H., & Maciel, P. (2007) · The FASEB Journal · doi:10.1096/fj.06-7002com · Cited by 104
Self-citationTodi, S. V., Scaglione, K. M., Blount, J. R., Basrur, V., Conlon, K. P., Pastore, A., Elenitoba‐Johnson, K. S. J., & Paulson, H. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.181610 · Cited by 102
Self-citationInhibition of Rho kinases enhances the degradation of mutant huntingtin
Bauer, P. O., Wong, H. K., Oyama, F., Goswami, A., Okuno, M., Kino, Y., Miyazaki, H., & Nukina, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809229200 · Cited by 102
Identification of the Drosophila Ortholog of HSPB8
Carra, S., Boncoraglio, A., Kanon, B., Brunsting, J. F., Minoia, M., Rana, A., Vos, M. J., Seidel, K., Sibon, O. C. M., & Kampinga, H. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127498 · Cited by 102
Sudarsky, L. R., & Coutinho, P. (1995) · PubMed · Cited by 102
Mishra, A., Dikshit, P., Purkayastha, S., Sharma, J., Nukina, N., & Jana, N. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706620200 · Cited by 101
Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease
Alves, S., Régulier, E., Nascimento-Ferreira, I., Hässig, R., Dufour, N., Koeppen, A. H., Carvalho, A. L., Simões, S., de Lima, M. C. P., Brouillet, E., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn106 · Cited by 100
Araujo, J., Breuer, P., Dieringer, S., Krauß, S., Dorn, S., Zimmermann, K., Pfeifer, A., Klockgether, T., Wuellner, U., & Evert, B. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr197 · Cited by 98
Chou, A.-H., Chen, S.-Y., Yeh, T., Weng, Y.-H., & Wang, H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.019 · Cited by 95
Igarashi, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.923 · Cited by 95
Lessing, D., & Bonini, N. M. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060029 · Cited by 94
The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis
Kuhlbrodt, K., Janiesch, P. C., Kevei, É., Segref, A., Barikbin, R., & Hoppe, T. (2011) · Nature Cell Biology · doi:10.1038/ncb2200 · Cited by 94
A mitochondrial ubiquitin ligase MITOL controls cell toxicity of polyglutamine-expanded protein
Sugiura, A., Yonashiro, R., Fukuda, T., Matsushita, N., Nagashima, S., Inatome, R., & Yanagi, S. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.09.001 · Cited by 92
Neocortical Atrophy in Machado‐Joseph Disease: A Longitudinal Neuroimaging Study
D’Abreu, A., França, M. C., Yasuda, C. L., Campos, B. A. G., Lopes‐Cendes, Í., & Cendes, F. (2011) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2011.00614.x · Cited by 88
Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation
Robertson, A. L., Headey, S. J., Saunders, H. M., Ecroyd, H. W., Scanlon, M. J., Carver, J. A., & Bottomley, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914773107 · Cited by 82
The spinocerebellar ataxias: Order emerges from chaos
Margolis, R. L. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0072-8 · Cited by 81
The UBL domain of PLIC‐1 regulates aggresome formation
Heir, R., Ablasou, C., Dumontier, É., Elliott, M., Fagotto‐Kaufmann, C., & Bedford, F. K. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400823 · Cited by 81
Machado–Joseph disease gene products carrying different carboxyl termini
Goto, J., Watanabe, M., Ichikawa, Y., Yee, S.-B., Ihara, N., Endo, K., Igarashi, S., Takiyama, Y., Gaspar, C., Maciel, P., et al. (1997) · Neuroscience Research · doi:10.1016/s0168-0102(97)00056-4 · Cited by 80
Schöls, L. J., Amoiridis, G., Epplen, J. T., Langkafel, M., Przuntek, H., & Rieß, O. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.5.466 · Cited by 80
Ellisdon, A. M., Pearce, M. C., & Bottomley, S. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.058 · Cited by 80
Gales, L., Cortes, L., Almeida, C. M., Melo, C. V., Costa, M. D. C., Maciel, P., Clarke, D. T., Damas, A. M., & Macedo‐Ribeiro, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.08.061 · Cited by 80
Self-citationJosephin domain of ataxin‐3 contains two distinct ubiquitin‐binding sites
Nicastro, G., Masino, L., Esposito, V., Menon, R. P., Simone, A. D., Fraternali, F., & Pastore, A. (2009) · Biopolymers · doi:10.1002/bip.21210 · Cited by 79
Increased transcript diversity: novel splicing variants of Machado–Joseph Disease gene (ATXN3)
Bettencourt, C., dos Santos, C. M. P., Montiel, R., Costa, M. D. C., Cruz‐Morales, P., Santos, L. R., Simões, N., Kay, T. T., Vasconcelos, J., Maciel, P., et al. (2009) · Neurogenetics · doi:10.1007/s10048-009-0216-y · Cited by 79
Self-citationEvert, B. O., Wüllner, U., Schulz, J. B., Weller, M., Groscurth, P., Trottier, Y., Brice, A., & Klockgether, T. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1169 · Cited by 77
Eichler, L., Bellenberg, B., Hahn, H. K., Köster, O., Schöls, L. J., & Lukas, C. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2387 · Cited by 76
Functional interactions as a survival strategy against abnormal aggregation
Masino, L., Nicastro, G., Calder, L. J., Vendruscolo, M., & Pastore, A. (2010) · The FASEB Journal · doi:10.1096/fj.10-161208 · Cited by 76
Silva‐Fernandes, A., Costa, M. D. C., Duarte‐Silva, S., Oliveira, P., Botelho, C., Martins, L., Mariz, J. A., Ferreira, T., Pinto‐Ribeiro, F., Correia‐Neves, M., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.021 · Cited by 75
Self-citationRüb, U., de Vos, R. A. I., Brunt, E. R. P., Sebesteny, T., Schöls, L. J., Auburger, G. W. J., Böhl, J., Ghebremedhin, E., Gierga, K., Seidel, K., et al. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00022.x · Cited by 67
Self-citationHomozygous inheritance of the Machado‐Joseph disease gene
Lang, A. E., Rogaeva, E. A., Tsuda, T., Hutterer, J., & George‐Hyslop, P. S. (1994) · Annals of Neurology · doi:10.1002/ana.410360318 · Cited by 66
Nicastro, G., Todi, S. V., Karaca, E., Bonvin, A. M. J. J., Paulson, H. L., & Pastore, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012430 · Cited by 66
Self-citationA Major Role for Side-Chain Polyglutamine Hydrogen Bonding in Irreversible Ataxin-3 Aggregation
Natalello, A., Frana, A. M., Relini, A., Apicella, A., Invernizzi, G., Casari, C. S., Gliozzi, A., Doglia, S. M., Tortora, P., & Regonesi, M. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018789 · Cited by 64
Lopes‐Cendes, Í., Maciel, P., Kish, S. J., Gaspar, C., Silveira, I., Robitaille, Y., Clark, H. B., Koeppen, A. H., NANCE, M. A., Schut, L. J., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400211 · Cited by 63
Fei, E., Jia, N., Zhang, T., Ma, X., Wang, H., Liu, C., Zhang, W., Ding, L., Nukina, N., & Wang, G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.160 · Cited by 63
Harris, G. M., Dodelzon, K., Gong, L., Gonzalez‐Alegre, P., & Paulson, H. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013695 · Cited by 63
Self-citationNEDD8: A new ataxin-3 interactor
Ferro, A., Carvalho, A. L., Teixeira‐Castro, A., Almeida, C. M., Tomé, R. J., Cortes, L., Rodrigues, A. J., Logarinho, E., Sequeiros, J., Macedo‐Ribeiro, S., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.07.012 · Cited by 63
Onodera, O., Idezuka, J., Igarashi, S., Takiyama, Y., Endo, K., Takano, H., Oyake, M., Tanaka, H., Inuzuka, T., Hayashi, T., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430305 · Cited by 62
Takahashi, J., Tanaka, J., Arai, K., Funata, N., Hattori, T., Fukuda, T., Fujigasaki, H., & Uchihara, T. (2001) · Journal of Neuropathology and Experimental Neurology · doi:10.1093/jnen/60.4.369 · Cited by 60
Rüb, U., Seidel, K., Özerden, I., Gierga, K., Brunt, E. R. P., Schöls, L. J., de Vos, R. A. I., den Dunnen, W. F. A., Schultz, C., Auburger, G. W. J., et al. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.08.003 · Cited by 59
Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs
Hu, J., Gagnon, K. T., Liu, J., Watts, J. K., Syeda-Nawaz, J., Bennett, C. F., Swayze, E. E., Randolph, J., CHATTOPADHYAYA, J. B., & Corey, D. R. (2011) · Biological Chemistry · doi:10.1515/bc.2011.045 · Cited by 57
Absence of ataxin-3 leads to cytoskeletal disorganization and increased cell death
Rodrigues, A. J., Costa, M. D. C., Silva, T. L., Ferreira, D., Bajanca, F., Logarinho, E., & Maciel, P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.07.004 · Cited by 56
Self-citationPositron emission tomography (PET) in Machado-Joseph disease
Taniwaki, T., Sakai, T., Kobayashi, T., et al. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00242-0 · Cited by 56
Study of subcellular localization and proteolysis of ataxin-3
Pozzi, C., Valtorta, M., Tedeschi, G., Galbusera, E., Pastori, V., Bigi, A., Nonnis, S., Grassi, E., & Fusi, P. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.01.011 · Cited by 56
Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3
Jung, J., Xu, K., Lessing, D., & Bonini, N. M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp456 · Cited by 56
Khan, L. A., Bauer, P. O., Miyazaki, H., Lindenberg, K. S., Landwehrmeyer, G. B., & Nukina, N. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03895.x · Cited by 55
Fukutake, T., Shinotoh, H., Nishino, H., Ichikawa, Y., Goto, J., Kanazawa, I., & Hattori, T. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00335.x · Cited by 55
The Josephin domain determines the morphological and mechanical properties of ataxin-3 fibrils.
Masino, L., Nicastro, G., Simone, A. D., Calder, L., Molloy, J., & Pastore, A. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.02.056 · Cited by 54
Todi, S. V., Laço, M., Winborn, B. J., Travis, S. M., Wen, H., & Paulson, H. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704126200 · Cited by 51
Self-citationNucleocytoplasmic Shuttling Activity of Ataxin-3
Macedo‐Ribeiro, S., Cortes, L., Maciel, P., & Carvalho, A. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005834 · Cited by 51
Spinocerebellar ataxia, type 3 (SCA3) is genetically identical to Machado-Joseph disease (MJD).
Haberhausen, G., Damian, M., Leweke, F., & Müller, U. (1995) · Journal of Neurological Sciences · doi:10.1016/0022-510x(95)90927-i · Cited by 50
Machado-Joseph disease gene product identified in lymphocytes and brain.
Wang, G., Ide, K., Nukina, N., Goto, J., Ichikawa, Y., Uchida, K., Sakamoto, T., & Kanazawa, I. (1997) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.1997.6484 · Cited by 49
Tsai, H., Tsai, H.-J., & Hsieh, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.192 · Cited by 49
Identification and functional dissection of localization signals within ataxin-3
Antony, P. M. A., Mäntele, S., Mollenkopf, P., Boy, J., Kehlenbach, R. H., Rieß, O., & Schmidt, T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.020 · Cited by 49
Costa, M. D. C., GOMES‐DA‐SILVA, J., Miranda, C. J., Sequeiros, J., Santos, M. M., & Maciel, P. (2004) · Genomics · doi:10.1016/j.ygeno.2004.02.012 · Cited by 49
Self-citationGould, V. F. C., Goti, D., Pearce, D., Gonzalez, G. A., Gao, H., de León, M. B., Jenkins, N. A., Copeland, N. G., Ross, C. A., & Brown, D. R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.005 · Cited by 48
Nicastro, G., Habeck, M., Masino, L., Svergun, D. I., & Pastore, A. (2006) · Journal of Biomolecular NMR · doi:10.1007/s10858-006-9092-z · Cited by 47
Absence of Ataxin-3 Leads to Enhanced Stress Response in C. elegans
Rodrigues, A. J., Neves‐Carvalho, A., Teixeira‐Castro, A., Rokka, A., Corthals, G. L., Logarinho, E., & Maciel, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018512 · Cited by 41
Maciel, P., Gaspar, C., Guimarães, L., Goto, J., Lopes‐Cendes, Í., Hayes, S. M., Arvidsson, K., Dias, A., Sequeiros, J., Sousa, A., et al. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200264 · Cited by 40
LaLonde, D. P., & Bretscher, A. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158030 · Cited by 38
Nuclear Aggregation of Polyglutamine-expanded Ataxin-3
Breuer, P., Haacke, A., Evert, B. O., & Wüllner, U. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.036335 · Cited by 38
Dynamic regulation of molecular chaperone gene expression in polyglutamine disease
Huen, N. Y. M., & Chan, H. Y. E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.008 · Cited by 29
Ataxin‐3 is subject to autolytic cleavage
Mauri, P., Riva, M., Ambu, D., Palma, A. D., Secundo, F., Benazzi, L., Valtorta, M., Tortora, P., & Fusi, P. A. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05419.x · Cited by 29
Cis‐acting factors promoting the CAG intergenerational instability in Machado–Joseph disease
Martins, S., Coutinho, P., Silveira, I., Giunti, P., Jardim, L. B., Calafell, F., Sequeiros, J., & Amorim, A. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30624 · Cited by 28
Chang, W.-H., Tien, C., Chen, T.-J., Nukina, N., & Hsieh, M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.004 · Cited by 26
Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin
Mazzucchelli, S., Palma, A. D., Riva, M., D’Urzo, A., Pozzi, C., Pastori, V., Comelli, F., Fusi, P. A., Vanoni, M., Tortora, P., et al. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.08.003 · Cited by 25
Potassium channel dysfunction and depolarized resting membrane potential in a cell model of SCA3
Jeub, M., Herbst, M., Spauschus, A., Fleischer, H., Klockgether, T., Wüllner, U., & Evert, B. O. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.029 · Cited by 22
Casein kinase 2 interacts with and phosphorylates ataxin-3
Tao, R.-S., Fei, E., Ying, Z., Wang, H., & Wang, G. (2008) · Neuroscience Bulletin · doi:10.1007/s12264-008-0605-5 · Cited by 21
The human MJD gene: genomic structure and functional characterization of the promoter region
Schmitt, I., Evert, B. O., Khazneh, H., Klockgether, T., & Wüllner, U. (2003) · Gene · doi:10.1016/s0378-1119(03)00706-6 · Cited by 20
Hübener‐Schmid, J., & Rieß, O. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.01.005 · Cited by 19
[Clinical, genetic and pathological aspects of Machado-Joseph disease].
Coutinho, P., & Sequeiros, J. (1981) · PubMed · Cited by 19
Suppression of Polyglutamine Toxicity by the Yeast Sup35 Prion Domain in Drosophila
Li, L.-B., Xu, K., & Bonini, N. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705211200 · Cited by 15
Tower-Gilchrist, C., Fu, L., Gill, R. B., Prichard, M. N., Lesort, M. J., & Sztul, E. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.013 · Cited by 14
ATX-3, CDC-48 and UBXN-5: A new trimolecular complex in Caenorhabditis elegans
Rodrigues, A. J., Neves‐Carvalho, A., Ferro, A., Rokka, A., Corthals, G. L., Logarinho, E., & Maciel, P. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.092 · Cited by 13
Cited by
Klockgether, T., Mariotti, C., & Paulson, H. L. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0074-3 · Cited by 696
Self-citationPolyglutamine spinocerebellar ataxias — from genes to potential treatments
Paulson, H. L., Shakkottai, V. G., Clark, H. B., & Orr, H. T. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.92 · Cited by 373
Self-citationRüb, U., Schöls, L., Paulson, H., Auburger, G., Kermer, P., Jen, J. C., Seidel, K., Korf, H.-W., & Deller, T. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.01.001 · Cited by 346
Self-citation
Metadata
- Authors
- Costa, M. D. C., & Paulson, H. L.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 97
- Issue
- 2
- Pages
- 239-257
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W1986865371
- Cited by
- 260
- References
- 186
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.